Deep prepiriform cortex has an important role in modulating neurotransmission during limbic seizures. We used pharmacologic blockade of non-N-methyl-D aspartate (NMDA) receptors to study excitatory circuitry from the deep prepiriform cortex to the hippocampus dur ing global ischemia in rat. NBQX, a potent non-NMDA glutamate receptor antagonist, was microinjected stereo tactically into the deep prepiriform cortex before global ischemia for 10 min. Neuronal cell death in the hippocam-
Brain ischemia induces subsequent neuronal cell death in selectively vulnerable neurons of the hippo campus, cortex, and thalamus. The mechanism of this delayed neuronal necrosis is still uncertain. Elevated extracellular levels of excitatory amino acids (EAA), however, may have an initiating role in such cell death. NMDA (N-methyl-o-aspartate) and non NMDA receptor antagonists have protective effects on ischemic neuronal injury (Gill et aI., 1987; Shear down et aI., 1990) . Hypothermia decreases neuronal death in global ischemia by inhibiting EAA release (Busto et aI., 1989) . Another strategy to control EAA-induced injury in ischemia is to modify activity in excitatory neuronal networks because these net works may contain modulatory sites that affect dis tant targets. Receptor blockade or anatomic lesions at such modulatory sites can affect target-cell injury resulting from ischemia or seizures. For example, le sioning of the substantia nigra reduced striatal in-pus was evaluated quantitatively 72 h after ischemia. The NBQX-injected rats had a greater number of surviving cells in CA 1 sector of hippocampus than did saline-injected con trols or rats that received NBQX injections 1 mm from the target. Thus, excitatory amino acid-mediated circuitry ema nating from deep prepiriform cortex modulates ischemic neuronal injury in the hippocampus. Key Words: Global ischemia-Excitotoxicity-Excitatory amino acids-Isch emia-Delayed neuronal necrosis-NBQX. farction volume in focal ischemia (Buisson et aI., 1992) . Further, surgical removal of the entorhinal cortex inhibits hippocampal neuronal death in global ischemia (Jprgensen et aI., 1987) . Alternatively, mi croinjection of an NMDA receptor antagonist into the substantia nigra enhanced hippocampal cell in jury in kainate-induced seizures (Tanaka et aI., 1994) .
A region in the deep prepiriform cortex is a modu latory site for seizure propagation (Piredda and Gale, 1985) and has been referred to as the area tempestas (AT). Injection of pi co molar doses of bicuculline, a y-aminobutyric acid (GABA) receptor antagonist, into the AT induces limbic seizures. Although the circuitry from the AT is currently uncertain, immedi ate early gene (c-fos) or heat-shock protein (HSP72) expression in limbic structures, including the hippo campus, thalamus, and amygdala, may indicate that the circuitry involves these structures (Shimosaka, et aI., 1992; Maggio et aI., 1993) .
Local application of an NMDA receptor antago nist into the AT inhibits limibic seizures (Piredda and Gale, 1986) . Seizure-induced cell injury in limbic structures is also modulated through this anatomic system. Microinjection of an NMDA antagonist into the deep prepiriform cortex attenuates hippocampal injury in kainate-induced seizures, independent of seizure duration (Shimosaka et aI., 1994) . Also, injec-tion of the non-NMDA receptor antagonist NBQX into the AT attenuates HSP expression in the hippo campus 24 h following global ischemia (Simon and Kawaguchi, 1996) . Therefore, we studied the influ ence of NBQX injection into the AT on neuronal cell death 72 h after global ischemia. NBQX injection 1 mm away from the AT was examined to confirm the specificity of this effect.
MATERIALS AND METHODS

Implantation of guide cannulae
Twenty-nine male Sprague-Dawley rats weighing 300 to 350 g were used and divided into three groups: In Group I (n = 10), saline was injected into the AT: in Group II (n = 8), NBQX (Novo Nordisk) was injected into the AT; and in Group III (n = 11), NBQX was injected into a site 1 mm from the AT. The rats were anesthetized with 10% chloral hydrate (400 mg/kg i.p.) and mounted on a stereo taxic apparatus to implant two stainless-steel guide cannu lae (22G) for microinjection of NBQX or saline through internal-injection cannulae (28G) into the AT and one cannula for monitoring the brain temperature. Tips of the injection cannulae and a thermocouple probe for monitor ing brain temperature were projected 1.0 mm beyond the guide-cannulae tips. The coordinates of the AT were 3.8 mm anterior to bregma, 3.5 mm lateral to midline, and 6.5 mm below the dura with the incisor bar positioned 5 mm above the interaural line (Groups I and II). The coordinate of the site qway from the AT was 1 mm medial to AT (Group III). The site for monitoring brain temperature was in right striatum: 1 mm anterior to the bregma, 2.5 mm lateral to the midline, and 5 mm below the dura. The cannulae were attached to the skull with dental acrylate.
Four-vessel occlusion
Three days after implantation of the guide cannulae, four-vessel occlusion (Pulsinelli and Brierley, 1979) was performed. The rats were anesthetized initially by face mask with 3% halothane in a mixture of 67% N20 and 30% O2, Atropine sulfate (150 mg/kg) was administered intraperitoneally. After endotracheal intubation, the rats were ventilated mechanically by a rodent respirator with a mixture of 30% O2,69% N20, and 1 % halothane. Rectal temperature was monitored and maintained at 37.0::':: OSC with a heating pad throughout the experiments. The brain temperature was monitored by thermocouple probe in the right striatum and maintained at 37.0 ::':: 0.2DC by heating lamp. The left femoral artery was cannulated to monitor the MABP continuously and to provide serial measurements of arterial oxygen and carbon dioxide tensions, pH, and blood glucose. The left femoral vein was cannulated to adminis tered pancuronium bromide (0.2 mg/kg). Under an operat ing microscope, an incision was made behind the occipital bone directly overlying the first two cervical vertebrae. The paras pinal muscles were separatep from the midline, and the bilateral vertebral arteries were exposed and electro coagulated between the first and the second vertebrae. The common carotid arteries and external carotid arteries then were exposed bilaterally and the external carotid arteries ligated. Halothane was discontinued before drug injection into AT. NBQX or saline was microinjected into bilateral AT (Groups I and II), or NBQX was injected 1 mm away from the AT bilaterally (Group III) using a syringe pump 15 min before the induction of ischemia. NBQX was dis solved in 0. 1 ml of 0. 1 N NaOH, and 0.8 ml of 5.5% glucose was added; the pH adjusted to 8.0 with 0. 1 N HC!. This solution was diluted to 3.7 mg/ml (10 nmol/�!) with saline. The pH of the saline also was adjusted to 8.0 with 0. 1 N NaOH. Saline and NBQX microinjection rates were 0. 1 �l/min; the total volume equaled 0.5 �l (NBQX total dose was 5 nmol). The rats were subjected to 10 min of global ischemia (confirmed by EEG flattening) by clamping the common carotid arteries bilaterally using micro arterial clips.
Histology
The rats were sacrificed 72 h after four-vessel occlusion with 10% chloral hydrate (400 mg/kg i.p.) and perfused transcardially with saline (100 m!) and 4% paraformalde hyde (400 ml, 0. 1 M phosphate buffer at pH 7.4). The brains were removed, kept in the same fixative for 10 days at 4DC, embedded in paraffin, and cut to 6-�m sections. The sections were stained with cresyl violet. The site of drug injection was confirmed microscopically in each brain. The number of surviving cells in the 0.41-mm length of CA1b layer on bilateral hippocampal sides was counted by a blinded investigator.
Statistical analysis
Cell counts and physiological variables were evaluated statistically with one-way analysis of variance (ANOV A) followed by Scheffe's post hoc test. All values were ex pressed as mean::':: SD; p < 0.05 was regarded as significant.
RESULTS
Physiological variables
There were no significant differences in MABP, P a02, p aC02, pH, blood glucose, or brain tempera ture in the three groups (Table 1) .
Histology
In the saline-injected group (Group I), the number of surviving cells in CAl was decreased compared with controls ( Fig. lA, B) . In contrast, animals pre treated with NBQX injection into the AT (Group II) showed a large number of surviving cells in CAl (Fig. lC, D) . Animals in which NBQX was injected 1 mm from the AT (Group III) showed cell loss in CAl, similar to the saline group (Fig. IE, F) . The number of surviving cells in Group II was significantly greater than in Groups I and III (Fig. 2) .
DISCUSSION
The results presented here suggest that pharmaco logic blockade of EAA neurotransmission at the deep prepiriform cortex, a site that modulates neuro transmission in the limbic system, can provide neuro protection at a remote site during ischemia. In brain ischemia, elevation of extracellular EAA concentra tions activates target receptors, including NMDA, High-power view of (*) in A (x200). c:
Hippocampus from a brain with NBOX injection into AT (X25). 0: High-power view of (*) in C (X200). E: Hippocam pus from a brain with NBOX injection 1 mm from the AT (X25). F: High power view of (*) in E (X200). Bar = 40 p,m (A, C, E) and 5 p,m (8, D, F). non-NMDA, and metabotropic receptors, which leads to increases in intracellular free calcium levels and neuronal cell injury (Choi, 1987; Siesjb and Beng tsson, 1989) . Pharmacologic blockade of postsynaptic EAA receptors (Gill et aI., 1987; Swan et aI., 1988) or inhibition of EAA release (Meldrum et aI., 1992; Leach et aI., 1993) prevents hippocampal neuronal cell death in global ischemia or decreases infarct vol ume in focal ischemia. Physiological inhibition of EAA release using hypothermia also attenuates isch emic neuronal injury (Busto et aI., 1989) . Anatomical approaches that target this neuronal network in the brain have protective effects on ischemic neuronal injury. For example, lesions of the CA3 subsector (Benveniste et aI., 1984) , the dentate granular cell layer (Johansen et aI., 1986) , and the entorhinal cor tex (J0rgensen et aI., 1987) protect against CAl pyra midal cell death in global ischemia. Further, nigral lesions reduce striatal infarct volume in focal isch emia (Buisson et aI., 1992) . Thus, previous experi ments using lesioning techniques have demonstrated protection against hippocampal ischemic injury by interruption of limbic circuitry. We now provide a pharmacologic correlate and suggest a critical site of action. The deep prepiriform cortex contains a site, the AT that modulates neurotransmission in the limbic sys;em during seizures (Piredda and Gale, 1985) . Bi cuculline (a GAB A-receptor antagonist) or kainate (a non-NMDA agonist) injected into the AT induces limbic seizures. Microinjection of AP7, an NMDA receptor antagonist, into the AT prevents bicucul line-induced limbic seizures (Piredda and Gale, 1986 ). Immediate early gene expression (c-Ios) fol-lowing bicuculline-induced seizure propagation from AT suggested that the pathway responsible for these effects involved the piriform cortex, thalamus, and hippocampus (Maggio et aI., 1993) . Previously, the AT was shown to modulate neuronal hippocampal injury. NMDA-receptor blockade with the compet ititve antagonist AP7 injected into the AT decreased neuronal damage in the hippocampus resulting from limbic seizure induced by systemic kainate (Shimo saka et aI., 1994) , implying that blockade of excitatory neurotransmission at the AT resulted in neuroprotec tion at a remote site (hippocampal pyramidal cells) . This protective effect occurred without attenuation of the seizure duration.
We therefore applied this concept to another sys tem in which neuronal injury is induced by EAA toxicity: global ischemia. Pretreatment with NBQX, a non-NMDA antagonist, at the AT attenuates HSP72 expression, a marker of cell injury (Gonzalez et aI., 1989) , in both CAl and CA3 subsectors 24 h follow ing global ischemia (Simon and Kawaguchi, 1996) . Thus, excitatory circuitry from the AT affects both CAl and CA3 during brain ischemia. The data pre sented here extend this observation by demonstrating that non-NMDA blockade in AT attenuates neu ronal cell death as well as cell injury in the hippocam pal CAl subsector after global ischemia. Further, injection of NBQX 1 mm from the AT had no effect on hippocampal cell death, which implicates a specific site in the drug's action. Thus, the AT is an attractive site for modulating neuronal cell death in the hippo campus during global ischemia. The mechanism of such neuroprotection is not demonstrated by these experiments. Candidate mechanisms being explored include the induction of antiapoptotic gene expres sion, attenuation of death promotor gene product, and attenuation of hippocampal glutamate release in the setting of ischemia. The study also suggests a new target for neuroprotective compounds in ischemia. Perhaps neuroprotective drug binding to AT might predict neuroprotective efficacy in global ischemia.
